
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
The global market for Contract Development and Manufacturing Organizations (CDMOs) was estimated to be worth US$ 87130 million in 2023 and is forecast to a readjusted size of US$ 171100 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030
United States is the largest Contract Development and Manufacturing Organizations (CDMOs) market with about 33% market share. Europe is follower, accounting for about 30% market share.
The key players are Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi AppTech, Asymchem, Porton, Amatsigroup etc. Top 3 companies occupied about 11% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Development and Manufacturing Organizations (CDMOs), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Contract Development and Manufacturing Organizations (CDMOs) by region & country, by Type, and by Application.
The Contract Development and Manufacturing Organizations (CDMOs) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Development and Manufacturing Organizations (CDMOs).
Market Segmentation
By Company
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
Segment by Type:
API Development
Manufacturing
Drug Delivery
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Contract Development and Manufacturing Organizations (CDMOs) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Contract Development and Manufacturing Organizations (CDMOs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Contract Development and Manufacturing Organizations (CDMOs) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Contract Development and Manufacturing Organizations (CDMOs) Product Introduction
1.2 Global Contract Development and Manufacturing Organizations (CDMOs) Market Size Forecast
1.3 Contract Development and Manufacturing Organizations (CDMOs) Market Trends & Drivers
1.3.1 Contract Development and Manufacturing Organizations (CDMOs) Industry Trends
1.3.2 Contract Development and Manufacturing Organizations (CDMOs) Market Drivers & Opportunity
1.3.3 Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
1.3.4 Contract Development and Manufacturing Organizations (CDMOs) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Contract Development and Manufacturing Organizations (CDMOs) Players Revenue Ranking (2023)
2.2 Global Contract Development and Manufacturing Organizations (CDMOs) Revenue by Company (2019-2024)
2.3 Key Companies Contract Development and Manufacturing Organizations (CDMOs) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Contract Development and Manufacturing Organizations (CDMOs) Product Offered
2.5 Key Companies Time to Begin Mass Production of Contract Development and Manufacturing Organizations (CDMOs)
2.6 Contract Development and Manufacturing Organizations (CDMOs) Market Competitive Analysis
2.6.1 Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Development and Manufacturing Organizations (CDMOs) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 API Development
3.1.2 Manufacturing
3.1.3 Drug Delivery
3.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type
3.2.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value, by Type (2019-2030)
3.2.3 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Company
4.1.2 Biotechnology Company
4.1.3 Generic Company
4.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application
4.2.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value, by Application (2019-2030)
4.2.3 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region
5.1.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (2019-2024)
5.1.3 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (2025-2030)
5.1.4 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
5.2.2 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
5.3.2 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
5.4.2 Asia Pacific Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
5.5.2 South America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
5.6.2 Middle East & Africa Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value
6.3 United States
6.3.1 United States Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.3.2 United States Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.4.2 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.5.2 China Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.6.2 Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.7.2 South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.8.2 Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2019-2030
6.9.2 India Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Profile
7.1.2 Lonza Main Business
7.1.3 Lonza Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.1.4 Lonza Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.1.5 Lonza Recent Developments
7.2 Catalent
7.2.1 Catalent Profile
7.2.2 Catalent Main Business
7.2.3 Catalent Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.2.4 Catalent Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.2.5 Catalent Recent Developments
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Profile
7.3.2 Patheon (Thermo Fisher Scientific) Main Business
7.3.3 Patheon (Thermo Fisher Scientific) Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.3.4 Patheon (Thermo Fisher Scientific) Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.3.5 Aenova Recent Developments
7.4 Aenova
7.4.1 Aenova Profile
7.4.2 Aenova Main Business
7.4.3 Aenova Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.4.4 Aenova Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.4.5 Aenova Recent Developments
7.5 Siegfried
7.5.1 Siegfried Profile
7.5.2 Siegfried Main Business
7.5.3 Siegfried Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.5.4 Siegfried Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.5.5 Siegfried Recent Developments
7.6 Recipharm
7.6.1 Recipharm Profile
7.6.2 Recipharm Main Business
7.6.3 Recipharm Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.6.4 Recipharm Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.6.5 Recipharm Recent Developments
7.7 Strides Shasun
7.7.1 Strides Shasun Profile
7.7.2 Strides Shasun Main Business
7.7.3 Strides Shasun Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.7.4 Strides Shasun Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.7.5 Strides Shasun Recent Developments
7.8 Piramal
7.8.1 Piramal Profile
7.8.2 Piramal Main Business
7.8.3 Piramal Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.8.4 Piramal Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.8.5 Piramal Recent Developments
7.9 Metrics
7.9.1 Metrics Profile
7.9.2 Metrics Main Business
7.9.3 Metrics Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.9.4 Metrics Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.9.5 Metrics Recent Developments
7.10 AMRI
7.10.1 AMRI Profile
7.10.2 AMRI Main Business
7.10.3 AMRI Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.10.4 AMRI Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.10.5 AMRI Recent Developments
7.11 Famar
7.11.1 Famar Profile
7.11.2 Famar Main Business
7.11.3 Famar Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.11.4 Famar Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.11.5 Famar Recent Developments
7.12 WuXi AppTech
7.12.1 WuXi AppTech Profile
7.12.2 WuXi AppTech Main Business
7.12.3 WuXi AppTech Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.12.4 WuXi AppTech Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.12.5 WuXi AppTech Recent Developments
7.13 Asymchem
7.13.1 Asymchem Profile
7.13.2 Asymchem Main Business
7.13.3 Asymchem Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.13.4 Asymchem Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.13.5 Asymchem Recent Developments
7.14 Porton
7.14.1 Porton Profile
7.14.2 Porton Main Business
7.14.3 Porton Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.14.4 Porton Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.14.5 Porton Recent Developments
7.15 Amatsigroup
7.15.1 Amatsigroup Profile
7.15.2 Amatsigroup Main Business
7.15.3 Amatsigroup Contract Development and Manufacturing Organizations (CDMOs) Products, Services and Solutions
7.15.4 Amatsigroup Contract Development and Manufacturing Organizations (CDMOs) Revenue (US$ Million) & (2019-2024)
7.15.5 Amatsigroup Recent Developments
8 Industry Chain Analysis
8.1 Contract Development and Manufacturing Organizations (CDMOs) Industrial Chain
8.2 Contract Development and Manufacturing Organizations (CDMOs) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Contract Development and Manufacturing Organizations (CDMOs) Sales Model
8.5.2 Sales Channel
8.5.3 Contract Development and Manufacturing Organizations (CDMOs) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
Ìý
Ìý
*If Applicable.
